JAMA · 1974 · 395 citations · 16 references
MedicineNeurologyPharmacologyNeuropharmacologyNeuropsychiatryPsychopharmacologyAntipsychotic PharmacologyEpileptic EncephalopathiesMental IllnessPsychiatric Effects Of MedicationsCerebellar DysfunctionEnzymesHaloperidol PharmacologyLithium PharmacologyLithium TreatmentMedication-induced ManiaPsychotic Mania Management
Four acutely agitated manic patients were treated with a combined regimen of lithium carbonate and high‑dose haloperidol, a therapy previously used at Metropolitan Hospital without reported adverse effects. All four patients developed severe encephalopathic syndromes, including lethargy, fever, tremor, confusion, extrapyramidal and cerebellar dysfunction, leukocytosis, elevated serum enzymes, BUN, and glucose; two suffered irreversible brain damage and two had persistent dyskinesias, with no causal factors identified. JAMA 230:1283‑1287 (1974).
Four acutely agitated patients with diagnoses of mania were treated with a combined regimen of lithium carbonate and high doses of haloperidol—a form of therapy that had been used previously in Metropolitan Hospital without reported adverse effects. In these four, severe encephalopathic syndromes developed. Symptoms consisted of lethargy, fever, tremulousness, confusion, and extrapyramidal and cerebellar dysfunction, accompanied by leukocytosis and elevated levels of serum enzymes, blood urea nitrogen, and fasting blood glucose. Two patients suffered widespread, devastating, irreversible brain damage. Two others were left with persistent dyskinesias. Causal factors have not been identified. (<i>JAMA</i>230:1283-1287, 1974)
16
The permeability of frog muscle fibres to lithium ions
R. D. Keynes, Roy C. Swan · The Journal of Physiology · 1959 · 244 citations · Full text